Related Experiment Video
Updated: Feb 12, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease
A Sonnenberg1, K O Turner2, R M Genta2,3
1Division of Gastroenterology, Portland VA Medical Center and Oregon Health & Science University, Portland, OR, USA.
Aim:
Previous studies have found an increased risk for microscopic colitis (MC) associated with proton pump inhibitors. In patients with ulcerative colitis (UC) or Crohn's disease (CD), proton pump inhibitors have been associated with an increased risk for IBD flares and impaired outcomes. The aim of this study was to test the epidemiological associations between gastro-oesophageal reflux disease (GERD) and MC, UC or CD in a large database.
Method:
The Miraca Life Sciences Database is a national electronic repository of histopathological records of patients distributed throughout the entire USA. A case-control study evaluated whether the presence of Barrett's metaplasia, erosive oesophagitis on endoscopy or histological signs of reflux oesophagitis, clinical diagnosis of GERD or any GERD type affected the occurrence of MC, UC or CD among 228 506 subjects undergoing bidirectional endoscopy. Multivariate logistic regression analyses were used to calculate ORs and their 95% CI for the risk of MC, UC or CD associated with various types of GERD and were adjusted for age, sex and presence of Helicobacter pylori.
Results:
The analysis revealed an inverse relationship between GERD and different types of inflammatory bowel disease. The inverse relationships applied similarly to MC (mean = 0.62, 95% CI: 0.58-0.66), UC (mean = 0.89, 95% CI: 0.81-0.97) and CD (mean = 0.76, 95% CI: 0.69-0.85). It also applied to different forms of GERD, with a trend towards more pronounced inverse relationships associated with Barrett's metaplasia or erosive oesophagitis than clinical diagnosis of GERD.
Conclusion:
Gastro-oesophageal reflux disease is inversely associated with all forms of inflammatory bowel disease, such as MC, UC, or CD.
Insights
Gastro-oesophageal reflux disease (GERD) shows an inverse relationship with inflammatory bowel diseases like microscopic colitis (MC), ulcerative colitis (UC), and Crohn
Area of Science:
- Gastroenterology and Epidemiology
- Inflammatory Bowel Disease (IBD) Research
- Reflux Esophagitis Studies
Background:
- Proton pump inhibitors are linked to increased microscopic colitis (MC) risk.
- In ulcerative colitis (UC) and Crohn's disease (CD) patients, proton pump inhibitors correlate with IBD flares and poorer outcomes.
- Existing research suggests potential links between GERD and IBD, but large-scale epidemiological data is limited.
Purpose of the Study:
- To investigate the epidemiological associations between gastro-oesophageal reflux disease (GERD) and MC, UC, or CD.
- To analyze the impact of various GERD manifestations on the incidence of these inflammatory bowel diseases.
- To clarify the relationship between GERD and IBD in a large patient cohort.
Main Methods:
- A case-control study utilized the Miraca Life Sciences Database, a national repository of histopathological records.
- Evaluated 228,506 subjects undergoing bidirectional endoscopy for associations between GERD indicators (Barrett's metaplasia, erosive esophagitis, clinical diagnosis) and MC, UC, or CD.
- Multivariate logistic regression analysis adjusted for age, sex, and H. pylori status to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
Main Results:
- A significant inverse relationship was observed between GERD and all studied forms of inflammatory bowel disease.
- The inverse association was consistent across microscopic colitis (OR=0.62), ulcerative colitis (OR=0.89), and Crohn's disease (OR=0.76).
- More pronounced inverse relationships were noted with Barrett's metaplasia or erosive esophagitis compared to a clinical GERD diagnosis.
Conclusions:
- Gastro-oesophageal reflux disease demonstrates an inverse epidemiological association with microscopic colitis, ulcerative colitis, and Crohn's disease.
- The findings suggest a potential protective effect of GERD against the development of these IBDs.
- Further research is warranted to elucidate the underlying mechanisms of this observed inverse relationship.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

